Swiss Biotech Allegria Therapeutics Secures $5.1M Seed Extension Financing

Swiss biotech company Allegria Therapeutics secures a USD 5.1 million seed extension financing round, with ALK Abelló leading the investment.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here